Can urine dipstick predict an elevated serum creatinine?

Prior studies have suggested that point-of-care urine dipstick testing might serve as a rapid indicator of elevated serum creatinine levels. However, these findings were based on chart reviews, which may not capture real-world variability. Existing knowledge indicates that proteinuria and hematuria are commonly associated with kidney dysfunction. Yet, the diagnostic accuracy of these markers in predicting serum creatinine elevation remains unclear. No prior work had resolved how reliably these urine markers predict elevated creatinine in a clinical setting. This uncertainty motivated the need for a prospective study to validate these findings. The gap in evidence highlights the importance of confirming the utility of urine dipstick testing in emergency settings. This study aimed to address that gap by evaluating test characteristics in a real-world patient population.

The study aimed to assess the diagnostic accuracy of point-of-care urine dipstick testing for predicting elevated serum creatinine levels. The specific problem addressed was the lack of real-world validation for chart review findings. The motivation stemmed from the need for a rapid diagnostic tool in emergency medicine settings. Researchers sought to determine if proteinuria or hematuria could reliably indicate elevated creatinine. The study focused on patients undergoing routine urinalysis and serum testing. It aimed to calculate sensitivity, specificity, and predictive values for these markers. The goal was to provide evidence for or against the clinical utility of urine dipstick testing. This would inform emergency medicine practices regarding diagnostic workflows.

A prospective observational study was conducted at two urban hospitals with a high emergency department census. Researchers enrolled patients who had urinalysis, dipstick testing, and serum chemistry panels. Data collection occurred continuously over 18 hours per day using standardized forms. Trained assistants recorded demographic and clinical information. The study defined elevated creatinine as greater than 1.3 mg/dL. Statistical methods were used to calculate diagnostic test characteristics. Proteinuria and hematuria were evaluated as predictors of elevated creatinine. The sample size included over 5,000 patients with diverse demographics.

Of the 5,416 participants, 13.9% had elevated serum creatinine levels. Proteinuria or hematuria detected 82.5% of elevated creatinine cases. The sensitivity of the test was 82.5% with a confidence interval of 80-85%. Specificity was lower at 34.4% with a confidence interval of 33-36%. Positive predictive value was 16.9% with a confidence interval of 16-18%. Negative predictive value was higher at 92.4% with a confidence interval of 91-94%. Likelihood ratios showed a 1.3 increase for a positive test and a 0.5 decrease for a negative test. These results suggest moderate predictive value for elevated creatinine.

The study found that proteinuria or hematuria had high negative predictive value but moderate overall accuracy for elevated creatinine. The authors suggest that urine dipstick testing may not be a strong standalone diagnostic tool. They propose that while a negative test is reassuring, a positive result is not definitive. The findings indicate that additional diagnostic methods may be necessary. The researchers emphasize the importance of context in interpreting dipstick results. They note that specificity and positive predictive value remain limited. The study does not claim that dipstick testing is essential for diagnosing elevated creatinine. The authors recommend further research to refine the clinical utility of these markers.